Crescita Therapeutics Inc. (CRRTF)

Market Cap	6.41M
Revenue (ttm)	12.61M
Net Income (ttm)	-2.13M
Shares Out	n/a
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	19,847
Open	0.3300
Previous Close	n/a
Day's Range	0.3300 - 0.3300
52-Week Range	0.0210 - 0.4567
Beta	1.19
RSI	48.90
Earnings Date	Aug 8, 2025

About Crescita Therapeutics

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: CRRTF

Financial Performance

In 2024, Crescita Therapeutics's revenue was 19.58 million, an increase of 11.75% compared to the previous year's 17.52 million. Losses were -2.75 million, 38.5% more than in 2023.

Financial numbers in CAD